1,790 results on '"van den Brink, Marcel"'
Search Results
2. Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
3. Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease
4. Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets.
5. Author Correction: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
6. Allogeneic “Off-the-Shelf” CAR T cells: Challenges and advances
7. IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model
8. Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
9. Melanoma and microbiota: Current understanding and future directions
10. Circulating microbial cell–free DNA is increased during neutropenia after hematopoietic stem cell transplantation
11. Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity
12. The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremia
13. Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
14. Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota
15. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients
16. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality
17. A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
18. Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation
19. Low Kit expression identifies Hematopoietic Stem Cell subsets with enhanced lymphoid potential in mice and humans
20. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
21. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease
22. Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
23. Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease
24. A compilation of fecal microbiome shotgun metagenomics from hematopoietic cell transplantation patients
25. CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
26. The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT
27. Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species
28. Figure S2 from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
29. Supplementary Tables from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
30. Data from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
31. Preliminary Results of the Open-Label Phase of a 2-Part Phase 1b Study That Evaluates Safety, Tolerability, Pharmacokinetics, and Efficacy of Investigational Microbiome Therapeutic SER-155 in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT)
32. Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd
33. Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation
34. A High-Fiber Dietary Intervention (NUTRIVENTION) in Precursor Plasma Cell Disorders Improves Disease Biomarkers and Delays Progression to Myeloma
35. Nutrition perceptions, needs and practices among patients with plasma cell disorders
36. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
37. T cell regeneration after immunological injury
38. Maternal Programming of Social Dominance via Milk Cytokines
39. Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin
40. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
41. Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.
42. Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
43. Fecal Transplantation in Hematopoietic Transplantation
44. Soquelitinib, A Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase (ITK), is Active in Several Murine Models of T Cell-Mediated Inflammatory Disease
45. The gut microbiota is associated with immune cell dynamics in humans
46. Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients
47. IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice
48. Author Correction: Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients
49. Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development
50. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.